Gli altri portali
Notizie a Confronto
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
Partnership with Key Opinion Leaders and successful trainings
Press release Ecully, May 30, 2024 – 6 p.m. SPINEWAY organizes surgical training sessionsin the use of ESP and KAPHORN implantsThe Spineway Group, a specialist in innovative implants for the treatment of severe spine disorders, announces that it trained nearly 30 spine surgeons in the use of its product lines during a series of sessions held in April and May.These surgeons from several countries (Thailand, Indonesia, Vietnam, Tunisia, Switzerland and France) were...
Nasdaq GlobeNewswire
30/05/2024
Cold Laser Therapy Market worth $161.3 Million by 2031: Coherent Market…
Market Dynamics : The growth of the Cold Laser Therapy Market is driven by the rising prevalence of musculoskeletal conditions and increasing popularity of non-invasive pain relief therapies. Cold laser therapy is a non-invasive treatment method that uses light to stimulate healing responses at the cellular level. It helps reduce inflammation and swelling and alleviates pain related to various musculoskeletal conditions such as tendonitis, carpal tunnel syndrome, and arthritis...
PR Newswire
30/05/2024
VNA & PACS Market to be Worth $6.50 Billion by 2031 - Exclusive Report by…
Vendor Neutral Archive (VNA) is a medical archive system that allows planning and managing the life cycle of the medical files stored on it, while Picture Archiving and Communication System (PACS) is the system that electronically stores images. Both VNA & PACS play an important part in medical image management for aiding diagnosis, comparing images between patients or within the same patient at different time points to assess the progress of the disease, and evaluating prognosis. Vendor...
PR Newswire
30/05/2024
EssilorLuxottica: Result of the payment of dividends in shares and record of the…
Result of the payment of dividends in shares and record of the corresponding capital increaseCharenton-le-Pont, France(May 30, 2024 – 4:30 pm)– The Annual General Meeting of EssilorLuxottica has decided to grant to the shareholders the option to receive their dividend in shares. The price for newly issued shares for the payment of the dividend has been set at Euro 180.12 per share. This price corresponds to 90% of the average of the opening prices quoted on Euronext Paris over the...
Nasdaq GlobeNewswire
30/05/2024
High Potency Drug Market worth USD 379.20 Billion by 2031 - Says InsightAce…
High potency drugs are a growing segment in the pharmaceutical industry, characterized by their powerful biological activity and specificity. These drugs are designed to have a significant therapeutic effect at very low doses, often measured in micrograms or nanograms. This unique property makes them particularly useful for treating severe and life-threatening conditions such as cancer, where the intent is to deliver precise and targeted treatment to minimize side effects. High potency drugs...
PR Newswire
30/05/2024
Global Surgical Pliers Market to Exhibit Growth at a CAGR of ~5% by 2030 |…
Key Takeaways from the Surgical Pliers Market Report Key Takeaways from the Surgical Pliers Market Report To read more about the latest highlights related to the surgical pliers market, get a snapshot of the key highlights entailed in theGlobal Surgical Pliers Market Report Surgical Pliers Overview Surgical pliers are indispensable tools in the medical field, designed with precision and functionality to assist surgeons in a myriad of procedures. These versatile instruments...
PR Newswire
30/05/2024
"Disrupt" introduces Disrupt Health Impact Fund with leading business groups in…
Ms. Jantanarak Tuekaew, Partner of Disrupt Health Impact Fund added that, "Thailand has been ranked among the top ten in terms of health security and medical tourism. This presents an opportune moment for both Thai and foreign entrepreneurs. Disrupt Health Impact Fund is committed to investing in five key areas: Self Care, Preventive Care, Silver Age, Holistic Wellness, and Smart Hospital. The fund also aims to be the gateway to Southeast Asia for DeepTech companies in the healthcare sector…
PR Newswire
30/05/2024
Presentation of the Congress of the European Academy of Allergy and Clinical…
VALENCIA, Spain, May30, 2024(GLOBE NEWSWIRE) -- Under the theme "Revolutionizing Patient Care through the Power of Data Science," the congress will highlight the crucial role of Allergy and Clinical Immunology in advancing personalised care, data science, and a holistic approach to health. Kindly be invited to the press conference presenting the Congress of the European Academy of Allergy and Clinical Immunology (EAACI), which will bring together the world's leading allergy and...
Nasdaq GlobeNewswire
30/05/2024
TOOsonix receives MDR CE Mark for its new oncology and dermatology device
The certification allows TOOsonix to sell its flagship product, System ONE-M™, across the European Economic Area. Treatment of skin cancer and skin diseases can now be conducted in ways never before possible, providing more patient-friendly treatment than traditional procedures. The certification allows TOOsonix to sell its flagship product, System ONE-M™, across the European Economic Area. Treatment of skin cancer and skin diseases can now be conducted in ways never before possible…
PR Newswire
30/05/2024
Teikoku Pharma USA, Inc. Announces NMPA Approved Lidoderm® in China on May 8…
In the US, Lidoderm® is marketed by TPU Pharma (subsidiary of TPU) and its authorized generic lidocaine patch 5% is marketed by Endo USA, Inc. It is also marketed as Versatis® in Europe and Latin America by Grünenthal GmbH. Our lidocaine patch 5% has been marketed by our partners worldwide and over 3.7 billion patches have been delivered to patients since its launch. "Although this has been a long journey, we are happy to see Lidoderm® receive approval in China, an important market for our…
PR Newswire
30/05/2024
The Lancet Publishes Results from World's Largest Coronary CT Registry Showing…
Key study findings include: Key study findings include: "TheORFANstudy is an expanding global registry which will include long-term clinical and outcome data for 250,000 patients from around the world, and we are very pleased to publish these initial results," said Keith Channon , MD, Professor of Cardiovascular Medicine at theUniversity of Oxford, Caristo's Chief Medical Officer, and co-author ofThe Lancetpublication. "Coronary inflammation is a crucial piece of the puzzle in...
PR Newswire
30/05/2024
Press Release: Sanofi completes acquisition of Inhibrx, Inc.
Sanofi completes acquisition of Inhibrx, Inc.Paris, May 30, 2024.Sanofi announced today the completion ofits acquisition of Inhibrx, Inc. (“Inhibrx”). The acquisition adds SAR447537 (formerly INBRX-101) to Sanofi's rare disease pipeline, underscoring the company's commitment to pursuing differentiated and potential best-in-class medicines that build upon our existing strengths and capabilities.SAR447537 is a human recombinant protein that holds the promise of allowing alpha-1...
Nasdaq GlobeNewswire
30/05/2024
ZEISS announces OCT technology enhancements to better support growing era of…
Proven Analytics: As the largest reference database across all OCT devices in the U.S. market today, the ZEISS CIRRUS 6000 reference database now offers a comprehensive library of 870 healthy eyes, more than tripling the previous versions, with greater diversity, taking into account different optic disc sizes in addition to age. Elevating the standard of care for patients, the expanded reference database is a useful tool to facilitate individualized approaches to diagnoses and ocular health and…
PR Newswire
30/05/2024
Philips celebrates 1.9m liters of helium saved as it marks 1,111 helium-free MRI…
First to provide helium-free operations in 2018, Philips marks milestone during installation in Puerto RicoAmsterdam, the Netherlands and Bayamón, Puerto Rico – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and world leader in proven helium-free [1] MRI operations, today announced the 1,111th installation of its revolutionary BlueSeal 1.5T magnet, which took place in Puerto Rico's Vida Imaging & Breast Center (Bayamón, Puerto Rico). Beyond its...
Nasdaq GlobeNewswire
30/05/2024
Sebastian Professional to Broaden Artistic Vision and Empower Self-Expression…
"Becoming part of Sebastian Professional is a lifelong aspiration fulfilled for me. As Global Creative & Culture Director, I'm dedicated to fostering an inclusive space that celebrates individuality and creativity, fueling the aspirations of emerging talent. Our mission is to honor Sebastian Professional's legacy while reimagining its future as a trailblazing brand. Together, with our vibrant community, we'll blend tradition with innovation, sparking a global movement of self-expression…
PR Newswire
30/05/2024
SkylineDx's Merlin Assay stratifies Stage I/II cutaneous melanoma beyond SLNB…
CP-GEP Low-Risk patients demonstrated a melanoma specific survival of 99.7 at 5 years, while CP-GEP High-Risk patients had significantly heightened recurrence risk. The melanoma specific survival of the high-risk group was 42.2 at 5 years. CP-GEP Low-Risk patients demonstrated a melanoma specific survival of 99.7 at 5 years, while CP-GEP High-Risk patients had significantly heightened recurrence risk. The melanoma specific survival of the high-risk group was 42.2 at 5 years. Dr.Teresa...
PR Newswire
30/05/2024
Optellum showcases AI for precision lung cancer treatment at ASCO 2024
Early diagnosis offers patients curative treatment options. Unfortunately, some 30% to 60% of Stage I-II NSCLC patients will experience recurrence after surgery. Accurate prognosis of recurrence risk could enable thoracic oncology teams to optimize treatment early, for example, to tailor the extent of surgical resection and ensure neo-adjuvant and peri-operative treatments are offered to those at risk. To drug developers, it may enable risk-stratifying populations to increase treatment rates…
PR Newswire
30/05/2024
Bavarian Nordic and CEPI Partners to Advance Mpox Vaccination in Africa
African trial could potentially support licensure of mpox vaccine in endemic countries and expansion of current regulatory approvals to include childrenCEPI has awarded USD 6.5 million in funding to support the Phase 2 clinical trial which is projected to start later in 2024COPENHAGEN, Denmark / OSLO, Norway, May 30, 2024– Bavarian Nordic A/S (OMX: BAVA) and the Coalition for Epidemic Preparedness Innovations (CEPI) today announced a partnership to advance the development of Bavarian...
Nasdaq GlobeNewswire
30/05/2024
ADC Therapeutics to Participate in the Jefferies Global Healthcare Conference
A live webcast of the presentation will be available via the Events & Presentations page in the Investors section of ADC Therapeutics' website atir.adctherapeutics.com. A replay of the webcast will be available for approximately 30 days. About ADC Therapeutics ADC Therapeutics (NYSE: ADCT) is a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs). The Company is advancing its proprietary ADC technology to transform the treatment paradigm for...
Nasdaq GlobeNewswire
30/05/2024
Fortrea Introduces Comprehensive Solution to Improve Diversity and Inclusion in…
Leverages real-world data, patient insights and a systematic process to design, operationalize and measure the effectiveness of diversity action plans in clinical trials Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced its comprehensive and integrated solution to improve the diversity and inclusion (D&I) of participants in clinical trials. Fortrea's D&I solution is designed to expand patient access to participate in...
Nasdaq GlobeNewswire
30/05/2024
Tiziana Life Sciences Scientific Board Chairman to Receive Prestigious Award for…
Dr. Weiner, a distinguished researcher in the field of neurology and immunology, has dedicated his career to advancing our understanding of MS and pioneering novel therapeutic approaches. His groundbreaking work has significantly contributed to the development of innovative treatments, including intranasal foralumab, that have the potential to improve the lives of millions affected by this chronic autoimmune disease.“We are thrilled to see Dr. Howard Weiner recognized with the 'Giants of...
Nasdaq GlobeNewswire
30/05/2024
MolecuLight's Pioneering Fluorescence Imaging Technology Showcased in…
Key findings from the study include: Key findings from the study include: "These compelling results underscore the transformative impact of MolecuLight in burn wound management – yet another area of wound care where our technology drives change," said Anil Amlani, CEO at MolecuLight Inc. "By providing clinicians with real-time, objective data on bacterial presence, MolecuLight's fluorescence imaging technology empowers them to make more informed decisions, ultimately leading to…
PR Newswire
30/05/2024
Preliminary Clinical Data on Relma-Cel Injection in Adults with Active Systemic…
SLE is a chronic autoimmune disease causing widespread inflammation and tissue damage in the affected organs. There are about one million SLE patients in China, ranking the first worldwide in total numbers and the second in incidence rate. Current conventional therapies include corticosteroids, antimalarial drugs, non-steroidal anti-inflammatory drugs (NSAIDs), cytotoxic drugs and immunosuppressive/modulatory agents. However, conventional treatments are poorly tolerated over time, which affects…
PR Newswire
30/05/2024
Illusion Aligners Makes Record-Breaking Achievement with its Biggest Aligner in…
This Biggest Aligner holds impressive dimensions of 1900 mm (about 6.23 ft) in width and 1650 mm (about 5.41 ft) in height and was crafted meticulously using Taglus PETG material. This creation was carefully crafted in a diligent eight-step process, beginning with impression collection, pouring, and 3D model printing, followed by thermoforming and precise laser marking. It then underwent thorough finishing, polishing, and quality checking before being keenly packed. It was officially recorded on…
PR Newswire
30/05/2024
Altri Comunicati